The efficacy of complementory use of memantine in treatment of schizophrenia with chronic course
Phase 2
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT201306015605N1
- Lead Sponsor
- Clinical psychiatry research center, Tabriz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Exclusion criteria:
Substance abuse; IQ of less than 70; Medical history of other mental disorder; Other clinical and neurological disorders; Taking antipsychotic medications during last week or long acting antipsychotic medications during past month; Receiving ECT in the past two weeks; Sensitivity to Memantine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Schizophrenia severity. Timepoint: 6 monthes. Method of measurement: Clinical assesment.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: Two month after begining of the study. Method of measurement: Clinical assessment.